Dutch company of Blueprint Medicines, a US precision-therapy biopharmaceutical company, which holds European marketing authorisations and supplies its targeted medicines for systemic mastocytosis and certain cancers.
Chưa có bình luận nào.
Để lại đánh giá & nhận xét